IBA Notice of Half Year 2026 Results and Conference Call

HY26 results webcast to take place on 
Thursday, 27 August 2026 at 3 p.m. CEST

Louvain-la-Neuve, Belgium, 6 August 2026, 7 a.m. - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, announces today that it will publish its consolidated results for the half year 2026 on Thursday, 27 August 2026 at 7 a.m. CEST.

Conference Call Information

IBA’s management team will host a conference call and webcast conducted in English to present the half year results, followed by a Q&A session.

The conference call will be held on Thursday, 27 August 2026 at 3 p.m. CEST / 2 p.m. BST / 9 a.m. EDT / 6 a.m. PDT as a Teams webinar. To attend the webcast, register via this link.

The presentation will be available on IBA’s investor relations website and on: https://www.iba-worldwide.com/iba-half-year-2026-results-presentation-and-press-release  shortly before the call.

To ensure a timely connection, it is recommended that users register at least 15 minutes prior to the scheduled webcast.

***ENDS***

About IBA

IBA (Ion Beam Applications S.A.) is the world leader in particle accelerator technology. The company is the leading supplier of equipment and services in the fields of proton therapy, considered as one of the most advanced forms of radiation therapy available today, as well as industrial sterilization, radiopharmaceuticals and dosimetry. The company, based in Louvain-la-Neuve, Belgium, employs approximately 2,300 people worldwide. IBA is a certified B Corporation (B Corp) meeting the highest standards of verified social and environmental performance.

IBA is listed on the pan-European stock exchange EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB).

More information can be found at: www.iba-worldwide.com

CONTACTS

Thomas Pevenage
Investor relations
+32 10 475 890
[email protected]

Nathalie van Ypersele
Head of Communication and Sustainability

Daniel Ernult
Corporate Communication Manager
+32 10 475 890
[email protected]

Attachment

• 260806-IBA-web-conf-announcement-HYR26-EN

You May Also Be Interested In

• MapLight Therapeutics Announces $150 Million Private Placement Financing 
• IceCure Highlights Two New Peer-Reviewed Publications Supporting Cryoablation in Breast Cancer Treatment De-Escalation
• CrowdStrike Expands Project QuiltWorks to SMBs, Extending Frontier AI Risk Protection to Organizations of Every Size